{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:28:32Z","timestamp":1790742512084,"version":"4.1.0"},"reference-count":122,"publisher":"BMJ","license":[{"start":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T00:00:00Z","timestamp":1485820800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To compare the effectiveness of alternative first line treatment options for women with WHO group II anovulation wishing to conceive.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review and network meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data sources<\/jats:title>\n                    <jats:p>Cochrane Central Register of Controlled Trials, Medline, and Embase, up to 11 April 2016.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study selection<\/jats:title>\n                    <jats:p>Randomised controlled trials comparing eight ovulation induction treatments in women with WHO group II anovulation: clomiphene, letrozole, metformin, clomiphene and metformin combined, tamoxifen, gonadotropins, laparoscopic ovarian drilling, and placebo or no treatment. Study quality was measured on the basis of the methodology and categories described in the Cochrane Collaboration Handbook. Pregnancy, defined preferably as clinical pregnancy, was the primary outcome; live birth, ovulation, miscarriage, and multiple pregnancy were secondary outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 2631 titles and abstracts initially identified, 54 trials reporting on 7173 women were included. All pharmacological treatments were superior to placebo or no intervention in terms of pregnancy and ovulation. Compared with clomiphene alone, both letrozole and the combination of clomiphene and metformin showed higher pregnancy rates (odds ratio 1.69, 95% confidence interval 1.33 to 2.14; 1.71, 1.28 to 2.27; respectively). Letrozole led to higher live birth rates when compared with clomiphene alone (1.67, 1.11 to 2.49). Metformin led to lower multiple pregnancy rates compared with clomiphene alone (0.22, 0.05 to 0.93).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In women with WHO group II anovulation, letrozole and the combination of clomiphene and metformin are superior to clomiphene alone in terms of pregnancy. Compared with clomiphene alone, letrozole is the only treatment showing a significantly higher rate of live birth.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>PROSPERO CRD42015027579.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Readers\u2019 note<\/jats:title>\n                    <jats:p>This is the second version of this paper. The original version was corrected following the retraction of two studies and removal of another which were ineligible (references 40, 41, and 75 of the original paper). These studies are not shown in this version. A tracked changes version of the original version is attached as a supplementary file to the correction notice, which explains the issue further.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmj.j138","type":"journal-article","created":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T06:35:14Z","timestamp":1485844514000},"page":"j138","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":111,"title":["Treatment strategies for women with WHO group II anovulation: systematic review and network meta-analysis"],"prefix":"10.1136","author":[{"given":"Rui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobae V","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelon","family":"van Wely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil P","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest Hung Yu","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S","family":"Legro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siladitya","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben Willem J","family":"Mol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,1,31]]},"reference":[{"key":"2022110212000573000_356.jan31_1.j138.1","unstructured":"National Institute for Health and Care Excellence. Fertility: assessment and treatment for people with fertility problems. NICE guidance. 2013."},{"key":"2022110212000573000_356.jan31_1.j138.2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms019"},{"key":"2022110212000573000_356.jan31_1.j138.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(15)30642-6"},{"key":"2022110212000573000_356.jan31_1.j138.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"2022110212000573000_356.jan31_1.j138.5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098"},{"key":"2022110212000573000_356.jan31_1.j138.6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2350"},{"key":"2022110212000573000_356.jan31_1.j138.7","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S37559"},{"key":"2022110212000573000_356.jan31_1.j138.8","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dml036"},{"key":"2022110212000573000_356.jan31_1.j138.9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der396"},{"key":"2022110212000573000_356.jan31_1.j138.10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"2022110212000573000_356.jan31_1.j138.11","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms062"},{"key":"2022110212000573000_356.jan31_1.j138.12","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmt006"},{"key":"2022110212000573000_356.jan31_1.j138.13","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms044"},{"key":"2022110212000573000_356.jan31_1.j138.14","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms018"},{"key":"2022110212000573000_356.jan31_1.j138.15","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"5","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2022110212000573000_356.jan31_1.j138.16","article-title":"Aromatase inhibitors for subfertile women with polycystic ovary syndrome","volume":"2","author":"Franik","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2022110212000573000_356.jan31_1.j138.17","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002249.pub4","article-title":"Clomiphene and anti-oestrogens for ovulation induction in PCOS","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"2022110212000573000_356.jan31_1.j138.18","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmm026"},{"key":"2022110212000573000_356.jan31_1.j138.19","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms003"},{"key":"2022110212000573000_356.jan31_1.j138.20","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dms036"},{"key":"2022110212000573000_356.jan31_1.j138.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2914"},{"key":"2022110212000573000_356.jan31_1.j138.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b1147"},{"key":"2022110212000573000_356.jan31_1.j138.23","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1875"},{"key":"2022110212000573000_356.jan31_1.j138.24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jval.2011.04.002","article-title":"Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1","volume":"14","author":"Jansen","year":"2011","journal-title":"Value Health"},{"key":"2022110212000573000_356.jan31_1.j138.25","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1037"},{"key":"2022110212000573000_356.jan31_1.j138.26","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2385"},{"key":"2022110212000573000_356.jan31_1.j138.27","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.fertnstert.2014.08.002","article-title":"Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement","volume":"102","year":"2014","journal-title":"Fertil Steril"},{"key":"2022110212000573000_356.jan31_1.j138.28","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1093\/humrep\/deu218","article-title":"Improving the reporting of clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement dagger double dagger","volume":"29","year":"2014","journal-title":"Human Reprod"},{"key":"2022110212000573000_356.jan31_1.j138.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.11.018"},{"key":"2022110212000573000_356.jan31_1.j138.30","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions Cochrane Collaboration . 2011. http:\/\/handbook.cochrane.org\/."},{"key":"2022110212000573000_356.jan31_1.j138.31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076654"},{"key":"2022110212000573000_356.jan31_1.j138.32","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/1536867X1501500402","article-title":"Visualizing assumptions and results in network meta-analysis: The network graphs package","volume":"15","author":"Chaimani","year":"2015","journal-title":"Stata J"},{"key":"2022110212000573000_356.jan31_1.j138.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.03.016"},{"key":"2022110212000573000_356.jan31_1.j138.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.mefs.2013.05.002"},{"key":"2022110212000573000_356.jan31_1.j138.35","first-page":"i96","article-title":"Double blind cross-over randomized controlled trial comparing letrozole versus clomiphene citrate for ovulation induction in women with polycystic ovarian syndrome","volume":"30","author":"Amer","year":"2015","journal-title":"Hum Reprod"},{"key":"2022110212000573000_356.jan31_1.j138.36","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/den325"},{"key":"2022110212000573000_356.jan31_1.j138.37","doi-asserted-by":"publisher","DOI":"10.1177\/147323000603400109"},{"key":"2022110212000573000_356.jan31_1.j138.38","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.112372"},{"key":"2022110212000573000_356.jan31_1.j138.39","first-page":"195","article-title":"The use of letrozole for ovulation induction in infertile women with polycystic ovarian syndrome","volume":"29","author":"Aygen","year":"2007","journal-title":"Erciyes Tip Dergisi"},{"key":"2022110212000573000_356.jan31_1.j138.40","unstructured":"Reference removed from version 2 of this systematic review."},{"key":"2022110212000573000_356.jan31_1.j138.41","unstructured":"Reference removed from version 2 of this systematic review."},{"key":"2022110212000573000_356.jan31_1.j138.42","first-page":"31","article-title":"Enhanced ovarian folliclular development by metformin does not correlate with pregnancy rate: a randomized trial","volume":"6","author":"Basirat","year":"2012","journal-title":"Int J Fertil Steril"},{"key":"2022110212000573000_356.jan31_1.j138.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.04.026"},{"key":"2022110212000573000_356.jan31_1.j138.44","first-page":"i129","article-title":"Randomized trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in polycystic ovary syndrome","volume":"21","author":"Beigi","year":"2006","journal-title":"Hum Reprod"},{"key":"2022110212000573000_356.jan31_1.j138.45","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)01749-6"},{"key":"2022110212000573000_356.jan31_1.j138.46","first-page":"335","article-title":"[Indication of metformin in the management of hormonal dysfunction secondary to polycystic ovarian syndrome: prospective comparative study of 63 cases]","volume":"88","author":"Boudhr\u00e2a","year":"2010","journal-title":"Tunis Med"},{"key":"2022110212000573000_356.jan31_1.j138.47","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)35947-7"},{"key":"2022110212000573000_356.jan31_1.j138.48","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.51337"},{"key":"2022110212000573000_356.jan31_1.j138.49","first-page":"23","article-title":"Comparison of the effects of letrozole and clomiphene citrate on ovulation and pregnancy rate in patients with polycystic ovary syndrome","volume":"34","author":"Dehbashi","year":"2009","journal-title":"Iran J Med Sci"},{"key":"2022110212000573000_356.jan31_1.j138.50","first-page":"43","article-title":"The use of metformin to augment the induction of ovulation in obese infertile patients with polycystic ovary syndrome","volume":"6","author":"El-Biely","year":"2001","journal-title":"Middle East Fertil Soc J"},{"key":"2022110212000573000_356.jan31_1.j138.51","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8261"},{"key":"2022110212000573000_356.jan31_1.j138.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)48915-6"},{"key":"2022110212000573000_356.jan31_1.j138.53","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der401"},{"key":"2022110212000573000_356.jan31_1.j138.54","doi-asserted-by":"crossref","unstructured":"Jahan S . Comparative study of efficacy among metformin, clomiphene citrate and aromatase inhibitor (letrozole) as the first-line medication for ovulation induction, achievement of pregnancy and live birth in Asian women with polycystic ovarian syndrome: A prospective trial. Int J Gynaecol Obstet 2015;131:E503.","DOI":"10.18035\/emj.v3i1.334"},{"key":"2022110212000573000_356.jan31_1.j138.55","first-page":"265","article-title":"The efficacy of clomiphene citrate for induction of ovulation. A controlled study","volume":"11","author":"Johnson","year":"1966","journal-title":"Int J Fertil"},{"key":"2022110212000573000_356.jan31_1.j138.56","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq100"},{"key":"2022110212000573000_356.jan31_1.j138.57","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.106338"},{"key":"2022110212000573000_356.jan31_1.j138.58","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.170373"},{"key":"2022110212000573000_356.jan31_1.j138.59","first-page":"174","article-title":"The effect of administration of metformin on lipid profile changes and insulin resistance in patients with polycystic ovary syndrome","volume":"12","author":"Karimzadeh","year":"2007","journal-title":"Middle East Fertil Soc J"},{"key":"2022110212000573000_356.jan31_1.j138.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.02.078"},{"key":"2022110212000573000_356.jan31_1.j138.61","first-page":"46","article-title":"Induction ovulation in polycystic ovary patient with clomiphene citrate and letrozole","volume":"9","author":"Keikha","year":"2011","journal-title":"Iran J Reprod Med"},{"key":"2022110212000573000_356.jan31_1.j138.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.10.042"},{"key":"2022110212000573000_356.jan31_1.j138.63","first-page":"299","article-title":"Ovulation induction with clomiphene citrate and metformin in women with polycystic ovary syndrome","volume":"66","author":"Leanza","year":"2014","journal-title":"Minerva Ginecol"},{"key":"2022110212000573000_356.jan31_1.j138.64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063971"},{"key":"2022110212000573000_356.jan31_1.j138.65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1313517"},{"key":"2022110212000573000_356.jan31_1.j138.66","first-page":"E231","article-title":"Comparison of ovulation induction protocol for women with polycystic ovarian syndrome: A prospective randomized trial","volume":"131","author":"Liu","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"2022110212000573000_356.jan31_1.j138.67","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)61273-4"},{"key":"2022110212000573000_356.jan31_1.j138.68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.00966.x"},{"key":"2022110212000573000_356.jan31_1.j138.69","unstructured":"Lorzadeh N Kazemirad S Mohammadi Z . Comparison of effects letrozole and clomiphene citrate for ovulation induction in women with polycystic ovary syndrome. Iran J Obstet Gynecol Infertil 2011;14:13-9."},{"key":"2022110212000573000_356.jan31_1.j138.70","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1037269"},{"key":"2022110212000573000_356.jan31_1.j138.71","first-page":"905","article-title":"Comparison of the efficacy of letrozole and clomiphene citrate for ovulation induction in infertile women with polycystic ovary syndrome","volume":"8","author":"Mobusher","year":"2014","journal-title":"Pak J Med Health Sci"},{"key":"2022110212000573000_356.jan31_1.j138.72","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38867.631551.55"},{"key":"2022110212000573000_356.jan31_1.j138.73","first-page":"879","article-title":"Comparison of efficacy of letrozole and clomiphene citrate in ovulation induction for women with polycystic ovarian syndrome","volume":"6","author":"Nazik","year":"2012","journal-title":"Health Med"},{"key":"2022110212000573000_356.jan31_1.j138.74","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0110"},{"key":"2022110212000573000_356.jan31_1.j138.75","unstructured":"Reference removed from version 2 of this systematic review."},{"key":"2022110212000573000_356.jan31_1.j138.76","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-011-2091-7"},{"key":"2022110212000573000_356.jan31_1.j138.77","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(03)01695-9"},{"key":"2022110212000573000_356.jan31_1.j138.78","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.97789"},{"key":"2022110212000573000_356.jan31_1.j138.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2003.09.036"},{"key":"2022110212000573000_356.jan31_1.j138.80","first-page":"455","article-title":"Comparison between clomiphene citrate and metformin for induction of ovulatory cycles in infertile nonobese women with polycystic ovary syndrome","volume":"31","author":"Santonocito","year":"2009","journal-title":"Giornale Italiano di Ostetricia e Ginecologia"},{"key":"2022110212000573000_356.jan31_1.j138.81","doi-asserted-by":"crossref","unstructured":"Selim MF Borg TF . Letrozole and clomiphene citrate effect on endometrial and subendometrial vascularity in treating infertility in women with polycystic ovary syndrome. 2012;28:405-10.","DOI":"10.1089\/gyn.2012.0033"},{"key":"2022110212000573000_356.jan31_1.j138.82","first-page":"531","article-title":"Comparison of the effectiveness of clomiphene citrate, tamoxifen and letrozole in ovulation induction in infertility due to isolated unovulation","volume":"10","author":"Seyedoshohadaei","year":"2012","journal-title":"Iran J Reprod Med"},{"key":"2022110212000573000_356.jan31_1.j138.83","first-page":"1149","article-title":"Comparison of letrazole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation","volume":"65","author":"Sharief","year":"2015","journal-title":"J Pak Med Assoc"},{"key":"2022110212000573000_356.jan31_1.j138.84","doi-asserted-by":"publisher","DOI":"10.1016\/j.mefs.2010.11.004"},{"key":"2022110212000573000_356.jan31_1.j138.85","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei311"},{"key":"2022110212000573000_356.jan31_1.j138.86","unstructured":"Vegetti W Riccaboni A Columbo M Randomized study of induction of ovulation by two different molecules with antioestrogenic effects, in patients with chronic anovulation disorders. 1999;72(3 Suppl 1):S234-5."},{"key":"2022110212000573000_356.jan31_1.j138.87","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.07.1076"},{"key":"2022110212000573000_356.jan31_1.j138.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.12.002"},{"key":"2022110212000573000_356.jan31_1.j138.89","first-page":"36","article-title":"Efficacy of letrozole in ovulation induction compared to that of clomiphene citrate in patients with polycystic ovarian syndrome","volume":"55","author":"Zeinalzadeh","year":"2010","journal-title":"J Reprod Med"},{"key":"2022110212000573000_356.jan31_1.j138.90","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3109\/09513590.2015.1096337","article-title":"Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysis","volume":"31","author":"Roque","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"2022110212000573000_356.jan31_1.j138.91","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12929"},{"key":"2022110212000573000_356.jan31_1.j138.92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1513873"},{"key":"2022110212000573000_356.jan31_1.j138.93","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2778"},{"key":"2022110212000573000_356.jan31_1.j138.94","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505297"},{"key":"2022110212000573000_356.jan31_1.j138.95","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1659"},{"key":"2022110212000573000_356.jan31_1.j138.96","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1514916"},{"key":"2022110212000573000_356.jan31_1.j138.97","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmv029"},{"key":"2022110212000573000_356.jan31_1.j138.98","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.01.019"},{"key":"2022110212000573000_356.jan31_1.j138.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.01.011"},{"key":"2022110212000573000_356.jan31_1.j138.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2016.03.006"},{"key":"2022110212000573000_356.jan31_1.j138.101","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4235"},{"key":"2022110212000573000_356.jan31_1.j138.102","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw025"},{"key":"2022110212000573000_356.jan31_1.j138.103","doi-asserted-by":"publisher","DOI":"10.4158\/EP15748.DSCPT2"},{"key":"2022110212000573000_356.jan31_1.j138.104","unstructured":"National Health and Medical Research Council. Evidence-based guideline for the assessment and management of polycystic ovary syndrome (updated August 2015 - section 7.4 aromatase inhibitors). 2015 https:\/\/www.nhmrc.gov.au\/_files_nhmrc\/publications\/attachments\/pcos_guideline_updated_18082015_v3.pdf."},{"key":"2022110212000573000_356.jan31_1.j138.105","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0253"},{"key":"2022110212000573000_356.jan31_1.j138.106","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-015-0274-y"},{"key":"2022110212000573000_356.jan31_1.j138.107","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.09.041"},{"key":"2022110212000573000_356.jan31_1.j138.108","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem426"},{"key":"2022110212000573000_356.jan31_1.j138.109","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(16)34504-2"},{"key":"2022110212000573000_356.jan31_1.j138.110","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.07.230"},{"key":"2022110212000573000_356.jan31_1.j138.111","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(16)32551-8"},{"key":"2022110212000573000_356.jan31_1.j138.112","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414827"},{"key":"2022110212000573000_356.jan31_1.j138.113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108219"},{"key":"2022110212000573000_356.jan31_1.j138.114","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.03.014"},{"key":"2022110212000573000_356.jan31_1.j138.115","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew280"},{"key":"2022110212000573000_356.jan31_1.j138.116","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.fertnstert.2016.05.022","article-title":"Randomized controlled trial of letrozole, berberine, or a combination for infertility in the polycystic ovary syndrome","volume":"106","author":"Wu","year":"2016","journal-title":"Fertil Steril"},{"key":"2022110212000573000_356.jan31_1.j138.117","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-013-2808-x"},{"key":"2022110212000573000_356.jan31_1.j138.118","article-title":"Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome","volume":"6","author":"Farquhar","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2022110212000573000_356.jan31_1.j138.119","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7433.192"},{"key":"2022110212000573000_356.jan31_1.j138.120","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der141"},{"key":"2022110212000573000_356.jan31_1.j138.121","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des336"},{"key":"2022110212000573000_356.jan31_1.j138.122","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.09.004"}],"updated-by":[{"DOI":"10.1136\/bmj.o2436","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000}}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.j138","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.j138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T15:00:58Z","timestamp":1667401258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.j138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,31]]},"references-count":122,"alternative-id":["10.1136\/bmj.j138"],"URL":"https:\/\/doi.org\/10.1136\/bmj.j138","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727259196.793559363","asserted-by":"object"}]},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,31]]}}}